|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT02180555 |
|
Date of registration:
|
01/07/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Diabetes Mellitus After Intensive Care Admission
DIAFIC |
|
Scientific title:
|
Incidence and Predisposing Factors for the Development of Glucose Metabolism Disturbances and Diabetes Mellitus After Intensive Care Admission |
|
Date of first enrolment:
|
February 2012 |
|
Target sample size:
|
400 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT02180555 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Belgium
| | | | | | | |
|
Contacts
|
|
Name:
|
Philippe G Jorens, MD, PhD |
|
Address:
|
|
|
Telephone:
|
00323821 |
|
Email:
|
philippe.jorens@uza.be |
|
Affiliation:
|
|
|
|
Name:
|
Philippe G Jorens, MD, PhD |
|
Address:
|
|
|
Telephone:
|
00323821 |
|
Email:
|
|
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- = 18 years old)
- admitted for 36 hours or longer to the ICU
- still alive 6 months after ICU discharge
Exclusion Criteria:
- known Diabetes Mellitus or any other glucose tolerance disturbance
- an estimated short life expectancy
- pregnancy
- a history of transplantation or acute pancreatic disease
- language barrier preventing a clear understanding of the informed consent
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Stress Hyperglycemia
|
|
Diabetes Mellitus
|
|
Intervention(s)
|
|
Other: Oral glucose tolerance test
|
|
Primary Outcome(s)
|
|
Glucose metabolism disturbance
[Time Frame: 6-9 months after ICU discharge]
|
|
Secondary Outcome(s)
|
|
Patient characteristics predicting adverse outcome
[Time Frame: 6-9 months after ICU discharge]
|
|
Secondary ID(s)
|
|
EC 12/2/22
|
|
B300201213039
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|